Table 2.

Demographic and baseline clinical characteristics of 60 patients.

Characteristics	Etodolac group (n = 30)	Etodolac + eperisone group (n = 30)	P value (*NS)
Gender
Male	8	11	0.198*
Female	22	19
Age in years	51.33 ± 8.14	51.87 ± 6.88	0.594*
Weight in kg	63.07 ± 5.84	61.93 ± 5.44	0.125*
Disease duration (years)	2.19 ± 1.15	1.84 ± 1.23	0.144*
Pain (VAS) score	7.43 ± 0.63	7.37 ± 0.61	0.440*
Joint tenderness score	2.63 ± 0.49	2.50 ± 0.51	0.163*
Swelling score	1.87 ± 0.68	1.90 ± 0.84	0.844*
Erythema score	1.80 ± 0.66	1.87 ± 0.82	0.453*
Pain on movement score	2.43 ± 0.57	2.37 ± 0.56	0.401*
Functional capacity score	2.57 ± 0.57	2.43 ± 0.50	0.163*
Overall arthritic condition score	3.53 ± 0.57	3.47 ± 0.51	0.384*

Data are in mean ± S.D.